Lannett Company FDA Inspection Record

FEI 1819171 · Inspections, Form 483s, warning letters and import refusals

Lannett Company is an FDA-registered facility (FEI 1819171) located in Seymour, IN, US. Registered operations: ANALYSIS; LABEL; MANUFACTURE; PACK; RELABEL; REPACK. RegDataLab tracks 10 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Oct 21, 2022: Voluntary Action Indicated (VAI)
Inspections on record
10 (1 OAI, 9 VAI)
Last OAI inspection
Oct 31, 2012
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
16, latest Jun 26, 2026

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Oct 21, 2022Voluntary Action Indicated (VAI)No citations listed
Jul 23, 2018Voluntary Action Indicated (VAI)No citations listed
Feb 2, 2018Voluntary Action Indicated (VAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Batch production and Batch Control Record Requirements (21 CFR 211.188(b))
Dec 16, 2014Voluntary Action Indicated (VAI)No citations listed
Aug 15, 2013Voluntary Action Indicated (VAI)No citations listed
Oct 31, 2012Official Action Indicated (OAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Equipment Design, Size and Location (21 CFR 211.63)
Calibration/Inspection/Checking not done (21 CFR 211.68(a))
Extent of discrepancy, failure investigations (21 CFR 211.192)
and 2 more
Aug 29, 2012Voluntary Action Indicated (VAI)No citations listed
May 13, 2011Voluntary Action Indicated (VAI)Sanitation--buildings not clean, free of infestation (21 CFR 211.56(a))
Identification of containers, lines, equipment (21 CFR 211.105(a))
May 12, 2010Voluntary Action Indicated (VAI)No citations listed
Sep 2, 2009Voluntary Action Indicated (VAI)No citations listed

Recalls

Showing the 10 most recent of 16 recalls. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Jun 26, 2026Class IID-0660-2026Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate…
Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.
May 27, 2026Class IID-0584-2026Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by…
Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.
Apr 24, 2026Class IIID-0533-2026Primidone Tablets USP, 250mg, 100-count bottle, Rx only, Distributed by: Lannett Company…
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
Oct 10, 2025Class IID-0096-2026Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle…
Failed Dissolution Specifications
Aug 19, 2025Class IID-0642-2025Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and…
Presence of Foreign Tablet/Capsule: Two (2) bottles labeled as Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine…
Aug 11, 2025Class IID-0599-2025Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by…
Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules…
Oct 25, 2024Class IID-0112-2025Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed…
Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity.
Nov 9, 2022Class IIID-0160-2023Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, 1000 Capsules… and 1 more product
Failed Impurity/Degradation Specifications
Feb 21, 2019Class IIID-0996-2019Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed…
Failed Dissolution Specifications
Jul 7, 2015Class IID-1236-2015Nitroglycerin Transdermal System 0.2 mg/hr (10 cm2), For Transdermal Use Only, 30 Systems… and 1 more product
Failed Impurities/Degradation Specifications: failed specification for unknown impurity at the 24 month stability testing.

FDA record score

29 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

21 records behind this number
RecordDatePoints x age weightAdds
Class II recall D-0660-2026, this FEI as the recalling firmJun 26, 20264 x 14
Class II recall D-0584-2026, this FEI as the recalling firmMay 27, 20264 x 14
Class II recall D-0096-2026, this FEI as the recalling firmOct 10, 20254 x 14
Class II recall D-0642-2025, this FEI as the recalling firmAug 19, 20254 x 14
Class II recall D-0599-2025, this FEI as the recalling firmAug 11, 20254 x 14
Inspection classified VAIOct 21, 20226 x 0.63.6
Class II recall D-0112-2025, this FEI as the recalling firmOct 25, 20244 x 0.62.4
Inspection classified VAIJul 23, 20186 x 0.251.5
Inspection classified VAIFeb 2, 20186 x 0.251.5
Class II recall D-1236-2015, this FEI as the recalling firmJul 7, 201510 years or older, so it adds no points0
Inspection classified VAIDec 16, 201410 years or older, so it adds no points0
Class II recall D-009-2014, this FEI as the recalling firmSep 16, 201310 years or older, so it adds no points0
Inspection classified VAIAug 15, 201310 years or older, so it adds no points0
Inspection classified OAIOct 31, 201210 years or older, so it adds no points0
Inspection classified VAIAug 29, 201210 years or older, so it adds no points0
Inspection classified VAIMay 13, 201110 years or older, so it adds no points0
Inspection classified VAIMay 12, 201010 years or older, so it adds no points0
Class II recall D-686-2010, this FEI as the recalling firmApr 29, 201010 years or older, so it adds no points0
Inspection classified VAISep 2, 200910 years or older, so it adds no points0
Class II recall D-205-2008, this FEI as the recalling firmMar 21, 200810 years or older, so it adds no points0
Class II recall D-053-5, this FEI as the recalling firmOct 22, 200410 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 16, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Lannett Company as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Lannett Company yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Lannett Company LLC
Location
Seymour, IN (US)
Registration Expires
Dec 31, 2027
Operations
ANALYSIS; LABEL; MANUFACTURE; PACK; RELABEL; REPACK
Source
decrs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.